Asahi Kasei $1.1 billion offer to acquire Calliditas Therapeutics
We are advising Lazard as financial adviser to Calliditas on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
AnHeart Therapeutics acquisition by Nuvation Bio
We are advising AnHeart Therapeutics on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Sun Pharmaceutical enters into merger agreement with Taro Pharmaceutical
We are advising Sun Pharma on the transaction
Roche $295 million acquisition of LumiraDx's point of care technology platform
We are advising Roche on the acquisition
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition